Iguratimod attenuates general disease activity and improves lung function in rheumatoid arthritis-associated interstitial lung disease patients
CONCLUSIONS: Iguratimod attenuates general inflammation, disease activity, and improves lung function in RA-ILD patients.PMID:34337716 | DOI:10.26355/eurrev_202107_26379
Source: Pharmacological Reviews - Category: Drugs & Pharmacology Authors: P Shu S-Q Shao X-N Cai D-M Zhou H Ma L Lu H-Q Yin S-L Yin Source Type: research
More News: Arthritis | Carbon Monoxide Poisoning | CT Scan | Drugs & Pharmacology | Interstitial Lung Disease | Rheumatoid Arthritis | Rheumatology | Study